Walid Chemlali
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Cancer-related gene regulation, RNA modifications and cancer, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance(2020)123 cited
- → High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism(2018)107 cited
- → Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma(2018)99 cited
- → Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer(2019)97 cited
- → Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer(2016)91 cited
- → Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value(2016)90 cited
- → Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival(2018)67 cited
- → Immune gene expression in head and neck squamous cell carcinoma patients(2019)62 cited
- → Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts(2020)53 cited
- → ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels(2015)52 cited